A Study Comparing Capecitabine Capsule 500 mg (IntasPharmaceuticals Ltd., India) To The Reference Listed Drug XelodaÂ(Capecitabine 500 mg; Roche Pharmaceuticals) In Patients Of BreastCancer Or Colorectal Cancer Under Fed Condition

ABSTRACT: Intervention1: Capecitabine Extended Release Capsule 500 mg (Intas Pharma) : Dose: 1250 mg/m2, Frequency: twice daily, Mode of Administration: orally, Duration of treatment: One week Control Intervention1: Xeloda (Capecitabine) film coated tablets 500 mg (Roche Pharmaceuticals) : Dose: 1250 mg/m2, Frequency: twice daily, Mode of Administration: orally, Duration of treatment: One week Primary outcome(s): AUCTimepoint: Day 07 and Day 14

DISEASE(S): Malignant Neoplasm Of Colon, Unspecified

PROVIDER: 2577537 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR